Strides Pharma suspends sale of Ranitidine tab in US Medical Dialogues Bureau27 Sept 2019 9:56 AM ISTNew Delhi: Strides Pharma Science on Friday suspended the sale of Ranitidine tablets after it received an information request from the US health...
Lupin ropes in Jon Stelzmiller to head US specialty business Medical Dialogues Bureau26 Sept 2019 4:54 PM ISTNew Delhi: Homegrown pharma major Lupin on Wednesday announced appointment of Jon Stelzmiller as the President of its US specialty business....
GSK decides to recall antacid Zinetac over safety concern Medical Dialogues Bureau26 Sept 2019 4:54 PM ISTNew Delhi: GlaxoSmithKline Pharmaceuticals Ltd on Wednesday announced recall of ranitidine hydrochloride tablets produced in India using API sourced...
Biocon subsidiary acquires Chennai-based biological research facility from Pfizer Healthcare Medical Dialogues Bureau26 Sept 2019 2:08 PM ISTBiotechnology major Biocon on Tuesday said its subsidiary has acquired a Chennai-based biological research facility from Pfizer Healthcare for an...
Alembic JV Aleor Derma gets 1 USFDA observation for Karakhadi facility Medical Dialogues Bureau25 Sept 2019 1:53 PM ISTAleor Derma's formulation manufacturing facility located at Karakhadi, Gujarat got one observation after the completion of USFDA inspection. The...
CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers Farhat Nasim25 Sept 2019 1:19 PM ISTNew Delhi: To ensure patient safety, the country's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has ordered an...
Zydus Cadila: USFDA classifies Ankleshwar facility as No Action Indicated Medical Dialogues Bureau25 Sept 2019 9:45 AM ISTThe US Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 22-26, 2019. The EIR report stated that the...
Anuh Pharma successfully clears USFDA inspection Medical Dialogues Bureau25 Sept 2019 9:30 AM IST"We are pleased to inform you that a successful accomplishment at Anuh Pharma Ltd. was inspected by USFDA (United States Food and Drug Administration)...
Cipla employee settles case with SEBI, pays Rs 3 lakh Medical Dialogues Bureau25 Sept 2019 9:25 AM ISTSEBI, during its preliminary examination, observed that there was a delay on the part of Pathak in making a disclosure to the company under SEBI's PIT...
13 medical outlets violate provisions of Drugs and Cosmetics Act, licenses suspended Farhat Nasim25 Sept 2019 9:00 AM ISTLicenses of the erring establishments -- five in Jammu city, three at Bari Brahmna and five at R S Pura -- were suspended for violating provisions of...
Biocon acquires Pfizer RnD facility to boost biosimilars portfolio Farhat Nasim24 Sept 2019 3:44 PM ISTBiocon Biologics has acquired Research and Development(RnD) capital assets from Pfizer Healthcare India Ltd.New Delhi: Biopharmaceuticals company,...
SEBI slaps fine of Rs 22 crore on Aurobindo Pharma, promoters for insider trading Farhat Nasim24 Sept 2019 12:00 PM ISTThe probe found that the promoter entities traded in the scrip of APL based on unpublished price sensitive information or UPSI pertaining to Aurobindo...
